Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Launches Chemically Defined Cell Culture Medium

Published: Tuesday, June 25, 2013
Last Updated: Tuesday, June 25, 2013
Bookmark and Share
Cellvento™ CHO-200 medium and complementary feeds provide efficient fed-batch culture.

Merck Millipore has launched Cellvento™ CHO-200 chemically defined cell culture medium, a product of non-animal origin that delivers robust cell growth and consistent high performance.

Accompanied by complementary Cellvento™ Feed products, the new medium is optimized specifically for fed-batch processes using CHO-S cell types expressing monoclonal antibodies.

Cellvento™ CHO-200 medium and its corresponding feeds do not contain hydrolysates or components of unknown composition, resulting in very good lot-to-lot consistency.

The formulation supports high cell density growth and extended culture duration as well as long duration of high cell viability. This facilitates the production of high protein titers and results in strong productivity and product quality.

Cellvento™ CHO-200 medium and Cellvento™ Feeds are produced in dry powder form at the company's cGMP facility, using fully traceable raw materials sourced from qualified suppliers, leading to reliable homogeneity that allows for effective powder dissolution and uniform component distribution. A liquid version of Cellvento™ CHO-200 medium will be introduced in the fall of 2013.

"The new Cellvento™ CHO-200 medium expands our existing CHO medium offerings, allowing us to fully support our customers as they switch to the production mode of operation," said Dr. Antoine Heron, Head of Biopharm Materials & Technologies.

Dr. Heron continued, "Our profiling and processing technologies for raw materials and cell culture media, which promote scalable and predictable performance, further differentiate Merck Millipore in the raw materials and cell culture media market. Combined with our deep expertise in regulatory requirements for pharmaceutical ingredients, we allow biopharmaceutical manufacturers to improve their process and increase their speed to market."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Incoming CEO and President
Udit Batra, Ph.D. will be responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.
Tuesday, April 15, 2014
Merck Millipore Announces Exclusive Agreement with Julphar Diabetes
Collaboration to offer non-animal origin, recombinant human insulin as cell culture media supplement.
Wednesday, August 08, 2012
Scientific News
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
“Secret Sauce” for Personalized, Functional Insulin-producing Cells
Researchers uncover molecular switch to make effective sugar-responsive, insulin-releasing cells in a dish, offering hope for diabetes therapy.
Insights into Early Human Embryo Development
Researchers at Karolinska Institutet and the Ludwig Cancer Research in Stockholm have conducted a detailed molecular analysis of the embryo’s first week of development.
Boosting Gene Transfer Capabilities
A new and highly efficient method for gene transfer has been developed.
Liver-On-Chip Tracks Dynamics of Cellular Function
Hebrew University’s liver-on-chip platform is uniquely able to monitor metabolic changes indicating mitochondrial damage occurring at drug concentrations previously regarded as safe.
EU Project Aims to Cure Type 1 Diabetes
Researchers develop organoids from insulin-producing cells for transplantation.
Hope for Combating Muscular Dystrophy
Decoding a sugar molecule and identifying a mechanism linking it to MS could help in the development of therapy for the disease.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!